Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Renal Cell Carcinoma

NCT02542202 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT02542202
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02542202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Renal Cell Carcinoma
Lead sponsor
University of Chicago
Phase
Not applicable
Overall status
Terminated
Start date
May 1, 2015
Completion date
March 23, 2023
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic renal cell cancer, recurrent renal cell carcinoma, stage iv renal cell cancer